No annual revenue total was found in SHUTTLE PHARMACEUTICALS HOLDINGS, INC.'s SEC filings.
Shuttle Pharmaceuticals Holdings, Inc. (SHPH) files with the SEC under industry code 2834, Pharmaceutical Preparations. As of Jun 30, 2026 it held $90,238 in cash and investments and $195,158 in total debt.
Revenue
—
Net income (TTM)
$-10.26M
+15.5% vs year-ago TTM
Operating cash flow (TTM)
$-6.58M
+37.7% vs year-ago TTM
Free cash flow
$-5.60M
EPS (TTM)
$-5.19
+95.2% vs year-ago TTM
Dividend per share
None
Shares outstanding
5.59M
+37.2% vs prior year
Net cash
$-104,920
as of Jun 30, 2026
Operating margin
—
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- SHPH (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Gaithersburg, MD
- SEC filer status
- , Emerging growth company
- SEC CIK
- 1757499
- Former names
- Shuttle Pharmaceuticals Holdings, Inc. (until Oct 22, 2026)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Key figures
Fiscal-year totals from the annual reports. Balance sheet lines are as of each year end.
| Line | FY 2025 Dec 31, 2025 |
FY 2024 Dec 31, 2024 |
FY 2023 Dec 31, 2023 |
FY 2022 Dec 31, 2022 |
|---|---|---|---|---|
| Operating income | -$11.9M | -$7.7M | -$5.9M | -$2.3M |
| Net income | -$11.7M | -$9.1M | -$6.6M | -$5.0M |
| Diluted EPS | -$7.16 | -$82.60 | -$3.53 | — |
| Operating cash flow | -$9.5M | -$7.3M | -$5.6M | -$2.7M |
| Free cash flow | — | — | -$5.6M | — |
| Total assets | $10.5M | $2.5M | $6.0M | $8.7M |
| Total liabilities | $8.2M | $1.8M | $1.9M | $975,676 |
| Stockholders' equity | $2.3M | $709,152 | $4.1M | $7.7M |
| Cash and investments | $334,005 | $1.9M | $5.5M | $8.4M |
| Total debt | $232,147 | $298,997 | $356,606 | $62,823 |
Recent SEC filings
| Form | Description | Filed | Period |
|---|---|---|---|
| 8-K |
Current report
Auditor change
|
Oct 22, 2026 | Oct 16, 2026 |
| 10-Q | Quarterly report | Sep 24, 2026 | Jun 30, 2026 |
| 8-K/A | Amended current report | Sep 24, 2026 | Sep 9, 2026 |
| 8-K |
Current report
Unregistered share sale
|
Sep 16, 2026 | Sep 9, 2026 |
| 8-K |
Current report
Shareholder vote results
|
Sep 11, 2026 | Sep 9, 2026 |
| 8-K |
Current report
Other events
|
Sep 2, 2026 | Sep 2, 2026 |
All 307 Shuttle Pharmaceuticals Holdings, Inc. SEC filings
Source: SEC EDGAR filings. This is company-reported data, not investment advice.